Epidemiology of Breast Cancer Selected Highlights Jack Cuzick, Ph.D Cancer Research UK London.

Slides:



Advertisements
Similar presentations
Known Causes of Breast Cancer for Women Rock! Crispin H Pierce, Ph.D. Environmental Public Health Program University of Wisconsin-Eau Claire.
Advertisements

Functional Capacity Disability threshold Fitness Gap age กราฟ A life-course perspective to maintain the highest possible level of functional capacity.
Breast Cancer Screening:
Breast Cancer. Dr. Swapna Chaudhary M.S. (MUM) M.S. (MUM) Consultant Obstetrician & Gynaecologist Infertility Specialist.
Periodic Woman Screening Sheet By Periodic Woman Screening Committee January 2010.
Breast MR Imaging Workshop th September 2014 High-Risk Screening Evidence-based Clinical Indications for Breast MRI Dr. Muhamad Zabidi Ahmad, AMDI.
Diet, Lifestyle and Breast Cancer Risk Barbour S Warren, PhD Program on Breast Cancer & Environmental Risk Factors Sprecher Institute for Comparative Cancer.
Sutter Pacific Medical Group of the Redwoods
Benign Breast Disease – Focus on Atypia Lynn C. Hartmann, MD Women’s Cancer Program Mayo Clinic Cancer Center.
Breast Cancer Risk and Risk Assessment Models
Epidemiology and risk factors for breast cancer DR.Mina tajvidi radiation oncologist.
Edmund Tai, MD Hematology/Oncology PAMF.  American Cancer Society Cancer Prevention Study-II  Harvard Nurses' Health Study (NHS)  Hawaii-Los Angeles.
22/10/1436. Addar Professor Gyneoncologist OB/GYN Dept. KKUH and College of Medicine MKing Saud University.
HEAPHY 1 & 2 DIAGNOSTIC James HAYES Fri 30 th Aug 2013 Session 2 / Talk 4 11:33 – 12:00 ABSTRACT To estimate population attributable risks for modifiable.
Breast cancer screening Recommendations for breast cancer screening چه شواهدی برای خطر وجود دارد؟ برای غربالگری چه باید کرد؟
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Breast Cancer Risk Factors
ASSESSMENT OF BREAST SYMPTOMS/LUMPS Professor P Grantley Gill Specialists Without Borders Seminar in Surgery Rwanda, September 2010.
Jo Anne Zujewski, MD Center for Global Health National Cancer Institute, U.S.A. Dar es Salaam September 11, 2014 Breast Cancer Risk Factors and Prevention.
Breast cancer: why do people get it and can we prevent it? T. Kuan Yu, M.D., Ph.D. Houston Precision Cancer Center.
Dr Jesme Baird The Roy Castle Lung Cancer Foundation, UK and ECPC.
Ovarian Cancer National Alliance Ovarian Cancer: What All Women Need to Know.
Cancers of the Reproductive System Review Session November 19, 2012.
Marion C.W. Henry, MD Yale University
1 Breast Cancer Risk Prediction Bernard Rosner Impact of Time-Dependent Risk Factors and Heterogeneity by ER/PR Receptor Status.
Epidemiology of breast cancer Rulla Tamimi, ScD Associate Professor of Medicine Harvard Medical School.
Menopause: The Journal of The North American Menopause Society
Ovarian Cancer Research in Allied Health Erin Brewer.
Kristi McIntyre M.D. Resident’s lecture
Jump to first page First pregnancy after age 30 (RR 1.48). BMI >29 (RR 1.48). Being a college graduate, independent of OB-GYN history (RR 1.36). (Collaborative.
Breast Carcinoma. Anatomy Epidemiology: 10% 17.1/10 28/10 46/ m world wide 6% develop cancer of the breast in their lifetime. 50,000 to 70,000.
Cancer Estimated US Cancer Cases Cancer Incidence Rates for Women, USA.
First month Second Month First month Second Month Milk line remnant Milk line remnant Accessory axillary breast tissue Accessory axillary breast tissue.
Risk factors and Epidemiology of Endometrial and Ovarian Cancer By: Tammy, Merissa, and Heather For: Nursing 519 Unit 6.
CASE: BREAST CANCER Alegre. Almora. Alonzo. Amaro. Amolenda. Anacta. Andal. Ang. Ang. Ang.
Pathology of The Breast- 1
Breast cancer -most common -Second common ( Death ) new case ( 2003 ) diagnosed - Lifetime Risk 2.5 % ( 1-8 )
Breast cancer ocure with involves genetic alterations of epithelial cell DNA, resulting in progressively more invasive and malignant somatic cells.
Ovarian Cancer Risk Reduction Taking oral contraceptives for 5 years can reduce your risk of ovarian cancer by up to 50% Hankinson SE, Colditz GA, Hunter.
IN THE NAME OF GOD BREAST DISEASE E.Naghshineh M.D.
Shiva Sharma SHO to Professor Redmond.  Introduction  Increased risk groups  Consideration of genetic testing  Management of patients with mutation.
Manzano, Clairol  Marcelo, Pamela Marcial, Karmi Margaret  Matematico, Michelle Matias, Evangelyn  Maulion, Marienelle.
March 10, 2014 NURS 330 Human Reproductive Health.
Personal Risk Factors Gender being a woman is the main risk factor for developing breast cancer (100 times more common in women) Age occurrence increase.
HEALTH PSYCHOLOGY Psychological Aspects of Breast Cancer.
Breast Cancer Prevention Art or Science? Kristi McIntyre M.D. Texas Oncology 2005.
BREAST CANCER: Half a million women later… Amy Miglani M.D September 3, 2004.
Epidemiology and risk factors for breast cancer
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
Pancreatic Cancer In 2012 there were 43,920 cases of pancreatic cancer. 10% of these cases have a family clustering of pancreatic cancers and associated.
Breast Cancer Surveillance Consortium (BCSC): A Research Infrastructure sponsored by the National Cancer Institute Breast Cancer Risk Models William Barlow,
Chemoprevention of cancer Dr Manal Kahwaji Cancer fighting day Feb 2, 2016.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Lesions of female breast are much more common than lesions of male breast Most of these lesions are benign Breast cancer is 2 nd most common cause of.
BREAST CANCER IS A DISEASE OF THE DEVELOPED WORLD POLINA USTYUZHANINA 1 EN 117 LINNEUNIVERSITETET MODULE 3 VT-13.
© Copyright Annals of Internal Medicine, 2016 Ann Int Med. 164 (6): ITC6-1. In the Clinic Breast Cancer Screening and Prevention.
Ari Brooks, MD Cancer Surgeon, Big Data End User
Endometrial hyperplasia
Clinical Pearls and Tools for Optimizing Breast Cancer Risk Assessment
Breast Cancer: The number speaks
Breast cancer: patterns and risk factors in older and younger women (June 2014) Breast cancer incidence is low in women under the age of 50 and has remained.
CLINICAL BREAST EXAMINATION
Dr. Sura Obay Al-Dewachi
Breast Health Katherine B. Lee, MD, FACP April 26, 2018.
Who in the room would offer BRCA1/2 testing to this patient Who in the room would offer BRCA1/2 testing to this patient? How might the medical management.
Figure 1 Differences in bladder cancer between genders
Volume 13, Issue 11, Pages (November 2012)
Marion C.W. Henry, MD Yale University
Gene promoter methylation analysis in ductal lavage fluid from cancer-free women at high risk for breast cancer and in women undergoing mastectomy for.
Presentation transcript:

Epidemiology of Breast Cancer Selected Highlights Jack Cuzick, Ph.D Cancer Research UK London

Major Factors Family history Reproductive/ Hormonal Benign Pathology Mammographic Density

Family History BRCA 1/2 Accounts for <5% of breast cancer. Important in some populations with founder mutations. Askenazi Jews Penetrance 50-80% Low penetrance genes – specific genes unknown Age at onset Multiple family members Bilaterality

Number of Relatives with Breast Cancer Number of first-degree relatives with breast cancer Cases (n=58 209) Controls (n= ) Risk ratio None or more

Age at Diagnosis - Relative Risk Woman’s age (years) Relative’s age at diagnosis of breast cancer <40 years40-49 years years >60 years < >

Alcohol – Cumulative Risk of Breast Cancer

Reproductive/ Childbirth Age 1 st childbirth – Nulliparous  First birth age = 30 years RR  3% / year Parity RR  - 7% / birth Breast Feeding  - 4.3% / year

Reproductive- Menstrual Factors Age at Menopause ~ 3% / year Age at Menarche ~ - 4% / year Oral Contraceptives 24% increase in current users only Hormonal Replacement Therapy 2.3% / year in current users only oestrogen + progestin twice as high ~ 5% /year.

Other Hormonal Weight – postmenopausal 1% increase / kg Height 1% increase / cm Alcohol ~ 7% per drink (10g) / day

Benign Breast Disease Lobular Carcinoma-in-situ ~ 10-fold risk Atypical Hyperplasia 4-fold risk Proliferative lesion without atypia. 2-fold risk

Mammographic Density Quantitative Effect High Attributable Risk > 50% density PAR = 33% > 75% density PAR = 15% (Boyd, et al. 1995) None<10% >75 Rel. Risk % of Controls

Estimating risks for individuals

Displaying the predictions

Summary output

Which factors involve Hormonal Regulation? Age at Menarche & Menopause Childbirth Weight Mammographic Density ?  At least partially Benign Breast Disease ?  Maybe Family History ?  Unclear

Which factors are associated with ER+ Cancers? Age at Menarche & Menopause ? Childbirth ? Weight ? Mammographic Density ? Benign Breast Disease ? Family History ?